OAS2
OAS2 (2'-5'-oligoadenylate synthase 2) is an interferon-induced, dsRNA-activated enzyme that contributes to the innate antiviral response. It synthesises 2'-5'-oligoadenylates from ATP, which in turn activate the latent endoribonuclease RNase L. Browse Assay Genie's current range of OAS2 research reagents below, or read on for the biology behind the target.
OAS2 is an interferon-induced antiviral enzyme that plays a critical role in the cellular innate response to viral infection. It is activated by detection of double-stranded RNA (dsRNA). Once active, it catalyses the formation of 2'-5'-oligoadenylates (2-5A) by polymerising ATP in 2'-specific nucleotidyl transfer reactions. These 2-5A molecules bind the inactive monomeric form of ribonuclease L (RNASEL), causing it to dimerise and become active. Active RNASEL degrades cellular and viral RNA, inhibiting protein synthesis and so terminating viral replication.
According to UniProt, OAS2 can mediate its antiviral effect through the classical RNASEL-dependent pathway or through an alternative pathway that does not depend on RNASEL. It may also have roles in other cellular processes, including apoptosis, cell growth, differentiation and gene regulation. A proposed role in lactation has also been described: the protein may act as a negative regulator, stopping lactation in virally infected mammary gland lobules and so limiting transmission of virus to neonates, while non-infected lobules remain unaffected. The protein is found in the cytoplasm, including the perinuclear region, and at the Golgi apparatus membrane.
The OAS2 gene encodes a member of the 2-5A synthetase family, and the protein belongs to the 2-5A synthase family. The three known members of this gene family lie in a cluster on chromosome 12, alongside OAS1 and OAS3, and the related protein OASL is also found in this family of interferon-responsive proteins. Alternatively spliced transcript variants encoding different isoforms have been described. The gene was formerly named 2'-5'-oligoadenylate synthetase 2 (69-71 kD), reflecting the protein forms first characterised. Mouse and rat both have an Oas2 ortholog.
OAS2 is an interferon-induced, dsRNA-activated enzyme central to the innate response that limits viral replication in infected cells.
By producing 2-5A, OAS2 activates RNASEL, leading to RNA degradation and inhibition of protein synthesis, making it a key node in this pathway.
As an interferon-induced gene, OAS2 serves as a readout of interferon-driven signalling and antiviral gene programmes.
OAS2 may contribute to apoptosis, cell growth, differentiation and gene regulation, extending its relevance beyond antiviral defence.
OAS2 is activated by double-stranded RNA and catalyses the formation of 2'-5'-oligoadenylates from ATP. These bind and activate RNase L, which degrades cellular and viral RNA, inhibits protein synthesis and halts viral replication. It can also act through an RNASEL-independent antiviral pathway.
The HGNC name is 2'-5'-oligoadenylate synthetase 2, with previous names that include the 69-71 kD and 69/71kDa forms. UniProt calls it 2'-5'-oligoadenylate synthase 2, and it belongs to the 2-5A synthase family. NCBI reports alternatively spliced transcript variants encoding different isoforms.
Mouse and rat each have an Oas2 ortholog. In humans, OAS2 is one of three known 2-5A synthetase genes clustered on chromosome 12, together with OAS1 and OAS3. Check the datasheet of any product for its validated reactivity.
Other 2-5A synthetase family members and related interferon-induced antiviral proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P29728; product specifications from Assay Genie datasheets.